My professional career began with a B.S. in Animal Science from the University of New Hampshire in 1983. I then went on to earn a Ph.D. in Biochemistry from Dartmouth College in 1991. My postdoctoral studies focused on human iron metabolism and the regulation of iron homeostasis through the Iron Responsive Element and the Iron Responsive Element Binding Proteins (IRE/IRE-BP) system. In 1995 I joined the faculty in the Department of Internal Medicine, in the Hematology Division. I continued to work on iron and heme, focusing on the eight steps in heme biosynthesis and the porphyric diseases associated with diminished activity. Administratively, I have had the responsibility for the Health Sciences Core Facilities, eighteen high technology facilities that provide data and services to the University community. I was also the Associate Dean for Research and Infrastructure, where my role is to advise on the use of space and to work with University groups to strategically develop resources to enhance research activity. I am also the Director of Cell Therapy and Regenerative Medicine (CTRM). At CTRM we process cells for the bone marrow transplant groups and develop novel regenerative medicine therapies. I joined the Abu Dhabi Stem Cell Center in 2022 to work on developing protocols and exploring the scientific basis for stem cell therapy. As the Director of Research and Innovation, my focus is on translational research that centers on stem cells, specialized cellular therapies, and regenerative medicine. Immune modulating therapies that address autoimmunity are actively studied, in ongoing clinical trials for Multiple Sclerosis and Type 1 Diabetes. Cell therapies for different cancers are being developed in collaboration with both academic and industrial partners.